awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38932150-5BDA573C-EB5E-4644-B7D3-30DC3D10A3A8
Q38932150-5BDA573C-EB5E-4644-B7D3-30DC3D10A3A8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38932150-5BDA573C-EB5E-4644-B7D3-30DC3D10A3A8
Biosimilars and the extrapolation of indications for inflammatory conditions.
P2860
Q38932150-5BDA573C-EB5E-4644-B7D3-30DC3D10A3A8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38932150-5BDA573C-EB5E-4644-B7D3-30DC3D10A3A8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b278b0011db9936708d7346e1c9f2935dbc3ef53
P2860
ECCO position statement: the use of biosimilar medicines in the treatment of inflammatory bowel disease (IBD).